Olema Pharmaceuticals, Inc. Common Stock
OLMAOlema Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on developing targeted therapies for women’s cancers. Founded to leverage innovative science, the company aims to address unmet medical needs in breast and ovarian cancers through novel approaches and personalized treatments.
Company News
Olema Pharmaceuticals plans to launch a public offering of common stock or pre-funded warrants, with TD Cowen acting as book-running manager. The offering is subject to market conditions and regulatory approvals.
Martin Shkreli announced shorting Olema Pharmaceuticals stock, criticizing the company's valuation in the SERD drug market. Despite Shkreli's stance, Olema's stock surged over 140% after positive phase 3 results from Roche's breast cancer study, with analysts raising price targets.
Olema's (OLMA) shares surge on the successful development of its lead candidate in metastatic breast cancer indication.
Watch for these 3 catalysts and consider these 6 stocks.
